The Natural Approach to Cancer
The Magazine Townsend Letter has published an article written by Sylvie Beljanski, the Vice-President of the Beljanski Foundation and daughter of Mirko Beljanski, Issue of August – September 2016. In the article titled “The Natural Approach to Cancer” Sylvie Beljanski explains that her father’s research has proved the correlation between the environment and its effects on the DNA. The environment, especially the one we are living in, with all the pollution and toxins for instance, constitutes one of the major causes of cancer. Mirko Beljanski is now considered as the father of Environmental Medicine for all the knowledge and progress his research brought to the war on cancer.
His dedication to find a cure to cancer of any kind with natural resources led him to discover natural extracts such as the Pao pereira, the Rauwolfia vomitoria, or the golden leaf of Ginkgo which help to re-organize a destabilized DNA.
Carrying on the legacy of Mirko Beljanski, and over the last 17 years The Beljanski Foundation has developed a research program with several high profile institutions to rigorously assess the anti-cancer potential of identified natural compounds.
All of those publications were published on peer reviewed Medical Journal and are available on Pubmed.gov (the US National Library of Medicine National Institutes of Health).
At Columbia University’s Department of Holistic Urology, preclinical and clinical studies were conducted with two plant extracts, Pao pereira and Rauwolfia vomitoria on prostate cancer cells and on men with prostate issues.
Advanced Cancer cells resistant to hormonal treatment at Nanjing University
The research team at Nanjing University used innovative techniques to demonstrate that the Pao pereira extract is effective even against prostate cancer cells that no longer responded to androgen deprivation therapy.
Pancreatic Cancer at Kansas University Medical Center
Research was recently completed at Kansas University Medical Center where the effects of Pao pereira and Rauwolfia vomitoria were analyzed on pancreatic cancer cells. Two new scientific articles were published confirming the excellent results of these studies and the synergy with conventional chemotherapies. Over the course of the study, the Pao pereira was seen to suppress tumor growth significantly, by up to 72% and Gemcitabine at the dose used did not provide any reduction in tumor weight, when Rauwolfia vomitoria alone decreased tumor weight by 53% at the daily dose of 20 mg/kg, and 46% at the daily dose of 50 mg/kg, compared with saline-treated control. By combining Rauwolfia vomitoria with Gemcitabine, the decrease in tumor weight was 56% at both Rauwolfia vomitoria doses.
Ovarian Cancer at Kansas University Medical Center
The scientific team found that Rauwolfia vomitoria was effective against ovarian cancer cells both alone and in combination with carboplatin. The combination decreased tumor size in animal experiments by 87 to 90% and a second study concludes that “In vivo, Pao pereira alone suppressed tumor growth by 79% and decreased volume of ascites by 55%. When Pao pereira was combined with carboplatin, tumor inhibition reached 97% and ascites was completely eradicated.
Clinical Trial on Thrombocytopenia at Cancer Treatment Center of America
Small RNA fragments that specifically trigger DNA synthesis in healthy bone marrow stem cells, were used in another clinical trial for platelet support. The data reveals that E. coli RNA fragments stimulate platelet proliferation in chemotherapy patients. The study also proved that the source from which the RNA fragments are prepared is critical. The study concluded that Patients receiving E. coli RNA fragments demonstrated a more rapid recovery in platelet count and higher nadir platelet count. None of the patients receiving the E. coli RNA fragments required a chemotherapy dose reduction due to thrombocytopenia.
For more details, you can read the full article click here: The Natural Approach to Cancer.
Article in the Dutch magazine The Optimist
With the exception of a special issue in the Spanish magazine La Revista de Medicinas Complementarias – Medicina Holística, most of the articles published about Mirko Beljanski have so far been usually written in either English or French.
A long article in Dutch, entitled “ Kan een plant kanker genezen? ”, dedicated to Mirko Beljanski, and his research, has been published in the Dutch magazine The Optimist.
Feel free to share it with your friends, information is the first step to taking care of your health after all !
Unless you get rid of the cancer stem cells, chances are the cancer will come back and radiotherapy and chemotherapy alone won’t do it. Cancer stem cells are a subpopulation of tumor cells that survive chemotherapy because they are drug resistant and are now thought to be the driving force behind tumor regrowth.
Research on cancer stem cells is difficult because it is hard to find direct evidence after tumor regression with chemotherapy that the residual cancer cells are stem cells, and that the tumor grows again from them. This is due in part to the technical difficulty of isolating and identifying these residual cancer cells.
So the question arises: are the Pao pereira and Rauwolfia vomitoria extracts that are so effective against primary cancer cells also active against cancer stem cells? The research group we’ve been working with at Kansas University Medical Center is starting a new research program to address this question. Dr. Qi Chen will use an assay known as ‘tumor spheroid formation’ to determine whether the Pao pereira and Rauwolfia vomitoria plant extracts have any effect on cancer stem cells. The principle is that under a special cell culture condition(in vitro), that favors cancer stem cell growth, non-stem cells die, and only cancer stem cells survive and generate new cancer cells to form spheres surrounding the stem cells. So the number of spheres can be counted to represent how many cancer stem cells are there.
Preliminary data using this assay with both extracts have been extremely positive and if these results are reproducible the Beljanski Foundation will design and fund an in vivo experiment… Stay tuned!
The broad spectrum anti-cancer activity of the Pao pereira and Rauwolfia vomitoria extracts has been proven by French and American research studies. Work from Dr. Aaron Katz’s lab at Columbia University Medical Center has shown that these two extracts posess a second activity, an anti-inflammatory effect in the human prostate.(1)
Inflammation is the body’s normal response to tissue injury, infection, toxic compounds, stress and other factors. Swelling, redness and fever are part of the response as cells of the immune system arrive at the affected tissues to fight the infection and initiate the repair process. But if the cause of the inflammation persists then the response is continuously triggered and the condition becomes chronic. Chronic prostate inflammation is fairly common in older men whose prostates become enlarged causing potentially serious urinary problems. This condition known as BPH (Benign Prostatic Hyperplasia), affects millions of men and there are few, if any, remedies without side effects.
Dr. Katz made an amazing observation: when men with urinary problems caused by BPH were given a combination of Pao pereira and Rauwolfia vomitoria, they experienced a dramatic improvement. This result demonstrated that the extracts have anti-inflammatory activity in the prostate and showed that the extracts reduce the size of the prostate, thus enabling normal urination.
The most interesting question from a scientific standpoint is how do the two extracts diminish inflammation in the prostate? In other words, what are their mechanisms of action? For example, previous work from Dr. Katz’s laboratory showed that in prostate cancer cells Pao pereira induces death through a process called apoptosis whereas Rauwolfia vomitoria stops the process of cell division which forces the cells to die. Do these same mechanisms apply when the extracts are applied to BPH cells? Or do they have an alternate action by reducing inflammatory signals and allowing the cells to return to normal?
Dr. Jun Yan and his research group at Nanjing University in China will determine how the extracts work. First, they will see what effect Pao pereira and Rauwolfia vomitoria have on the growth and viability of the BPH cells. Next, he will determine exactly how they interfere with inflammation at the biochemical level.
Dr. Yan has already studied the effect of the Pao pereira extract in advanced prostate cancer cells that no longer respond to hormone treatments(2). He found that Pao pereira specifically suppresses activation of the NFKB signaling pathway which is a major regulator of both inflammation and cancer progression. In the new experiments he will use techniques called gene expression profiling and gene ontology analysis that will trace all the active effects of Pao pereira and Rauwolfia vomitoria on inflammation pathways in BPH.
Clearly, the Pao pereira and Rauwolfia vomitoria extracts, so well known for their anti-cancer effects (3,4), are capable of doing more: they exhibit a potent anti-inflammatory effect in the prostate. And consider this: men purchasing the Pao pereira/Rauwolfia vomitoria combination for help with BPH get the anti-cancer effects for free!
(1)“Pao pereira Extract Suppresses Castration- Resistant Prostate Cancer Cell Growth, Survival and Invasion Through Inhibition of NFkB Signaling” by Cunjie Chang, BS, Wei Zhao, MS, Bingxian Xie, BS, Yongming Deng, BS, Tao Han, BM, Yangyan Cui, BS, Yundong Dai, BS, Zhen Zhang, BS, Jimin Gao, MD, PhD, Hongqian Guo, MD, PhD, and Jun Yan, PhD. – Integrative Cancer Therapies 2013, Vol XX(X) 1–10.
(2)“B-Carboline Alkaloid-Enriched Extract from the Amazonian Rain Forest Tree Pao Pereira Suppresses Prostate Cancer Cells” by Debra L. Bemis, PhD, Jillian L. Capodice, LAc, MS, Manisha Desai, PhD, Aaron E. Katz, MD, Ralph Buttyan, PhD – Journal of the Society for Integrative Oncology, Vol 7, No2
(3)“Anti-prostate cancer activity of B-carboline alkaloid enriched extract from Rauwolfia vomitoria” by D.L. Bemis, J.L. Capodice, P. Gorroochurn, A.E. Katz and R. Buttyan – International Journal of Oncology 29: 1065-1073
The inspirational stories below were written by amazing people who have experienced cancer firsthand, and we are happy to be able to honor them here. By sharing these accounts of courage, endurance, strength and even humor, we hope to share a common experience and provide encouragement.
“I’m a poster child for Beljanski’s botanicals. I feared the worst when my doctor told me that I had a PSA count of 19. My doctor told me it was almost certainly prostate cancer, and it had probably metastasized. I found out about these botanicals through Hugo House Publishers. I was skeptical, but I took them. Six weeks later my PSA count was down to 7. Then then it slipped to 5 and has stayed there for over a year.”
Rod W. from Denver, CO
“I could clearly see that the tumor in my breast, […], was growing again. I could feel it getting larger, the nipple was beginning to dimple, something it hadn’t done previously, and new blood vessels were forming just under the skin. It was scary. […]
Then along came this great book: Cancer’s Cause, Cancer’s Cure by Morton Walker. I downloaded it to my Nook and began reading the same day. I confidently ordered the herbal products which Dr. Beljanski had developed because of the years of painstaking research behind them, and their successful track record.”
Rebecca C. from Olympia WA
What is it like to be a patient fighting cancer?
Tell us your story of courage and love, and inspire other survivors and supporters around the world.
Share your story and experience with Mirko Beljanski’s discoveries today!
AMA-Accredited Continuing Medical Education is now available from The Beljanski Foundation. A Natural Approach to Cancer is a one-hour CME webinar presentation that provides AMA PRA Category 1 Credit™. The webinar also covers the cumulative destabilizing effect environmental toxins have on the physical structure of the DNA duplex and its secondary structure and natural non-toxic anti-cancer substances discovered by Mirko Beljanski, PhD that work at the DNA level.
Did you miss Dr. John Hall live interview about natural compounds with anti-cancer properties on Progressive Radio Network on November 3rd?
The interview is now available as a podcast on thenaturalnurse.podbean.com.
We all know someone who has cancer, bring awareness on integrative solutions by sharing this interview.
Read Now : “How to Prove a Natural Compound Can Treat Cancer” explains the rigorous scientific work of Mirko Beljanski, PhD that showed a causal link between cancer and exposure to carcinogens in the environment.
The article also provides an overview of the current research program the Foundation supports to validate and extend Dr. Beljanski’s original studies of natural extracts with non-toxic anti-cancer properties.
La Fundación Beljanski quiere expresar su gratitud al Señor Alfredo EMBID, coordinador general de la Asociación de Medicinas complementarias por su apoyo.En su revista n°82 recién publicada en España, la Asociación dedica, una vez más, gran parte del capítulo titulado « cáncer : Investigación actual », a los descubrimientos muy conocidos en Europa del profesor Mirko Beljanski, y más específicamente a la síntesis de los resultados en español de dos pruebas clínicas llevadas en EE. UU. (Estados Unidos) bajo la iniciativa de su hija Sylvie Beljanski, presidenta de Natural Source International, Ltd., confirmando de esta manera la pertinencia de los resultados conseguidos por su padre durante las investigaciones llevadas en el Instituto Pasteur, en Francia, hace muchos años atrás.
La prueba clínica, realizada por el CTCA (Cáncer Treatment Centers of America),demuestra que los fragmentos del ácido ribonucléico (ARN o RNA) puestos a punto por Mirko Beljanski, le permiten al organismo, después de un descenso inducido por la quimioterapia, estimular la producción de plaquetas y glóbulos blancos.La prueba clínica demuestra también que los fragmentos a base de levadura no igualan los resultados de los fragmentos de ARN Beljanski®, ni mucho menos.
por Mirko y Monique Beljanski (traducido del Frances), prólogo por Jesús M. de Miguel
Ed. Libros Límite
Resumen : Este libro abre un ancho camino de esperanza con el enfoque biológico y específico que expone. Los patientes conocerán que existe un tratamiento eficaz contra las graves enfermedades (cáncer, S.I.D.A., hemofilia, leucemia…) que padecen. Los cada vez más numerosos médicos, científicos e investigadores que reconocen que los tratamientos oficiales aplicados son escasamente efectivos pero enormemente perjudiciales (anticancerígenos que a su vez son cancerígenos, medicamentos contra el S.I.D.A. que aún debilitan más el sistema inmunológico, etc…), encontrarán las líneas maestras de una investigación que responde positivamente al reto que también ellos tienen planteado. Pero este libro va dirigido también a toda aquella persona preocupada por su salud. Los autores relatan en un estilo directo, claro y apasionado, los conflictos y silencios que existen en torno a la salud, cubiertos a menudo por un sospechoso velo.
Los autores: “Me indigna que cada día mueran niños a los que podríamos ayudar y, a veces, salvar. Que cancerosos con tumores resistentes podrían ser cuidados de otra manera. Que la calidad de vida de las personas tratadas únicamente con medios clásicos, podría ser fácilmente mejorada. Que los enfermos del SIDA mueren en la mayor desesperación cuando sería posible salvar un buen número de ellos. Que todo eso occure porque nuestra solución está frenada. No porque no funcione, no porque tenga efectos secundarios perjudiciales, nada de eso, sino únicamente porque existe un sistema, unos mandarines y unos clanes poderosos que se oponen a nuestras propuestas.”
Jesús M. de Miguel, Catedrático de Sociología de la Salud (Del Prólogo): “Este libro es una excelente crítica de la medicina oficial, del sector farmacéutico internacional dominante y des proprio sistema de investigación. Redactado en forma de un diario personal, entreverado de ‘descubrimientos’ y reflexiones, está escrito para un lector culto, contracultural, crítico. Pero además abre un camino de investigación frutífera en la lucha contra algunas de las enfermedades más terribles de la sociedad contemporánea. Se trata pues, de un camino a la esperanza.”
Ahora, este libro no es disponible a la venta.
Si quieres mas informaciones en Español sobre Mirko Beljanski y su trabajo, puedes leer estos artículos de prensa:
La luz, el cáncer y Fritz-Albert Popp y Nuevos proyectos de investigación sobre el tratamiento del cáncer de Mirko Beljanski
The generic name Rauwolfia, commemorates a 16th century German physician, Leonhart Rauvolf, who travelled widely to collect medicinal plants. The specific designation vomitoria refers to the purgative and emetic properties of the bark.
Rauwolfia vomitoria belongs to the family apocynacea. It is a shrub or small tree up to 26 feet (8 m). The parts that are commonly used for herbal remedies are roots, root bark, leaves and stem-bark. Roots may be harvested non-destructively annually by cutting them 4 inches (10 cm) from the taproot, allowing for fair-trade commercialization of this traditional remedy.
Modern science has studied the phytochemical constituents of Rauwolfia since the middle of the 20th century. The main alkaloid present is called reserpine and was first discovered by Swiss scientists, Schiller and Muller of CIB Pharmaceuticals in Switzerland in 1952. Reserpine is commonly used as a marker to identify Rauwolfia.
Reserpine, according to Okpako (1991), is a major constituent of antihypertensive drugs. Taken orally, Reserpine tablets treat the symptoms of high blood pressure (1) and psychotic illnesses such as schizophrenia. Reserpine lowers blood pressure by lowering certain chemicals in the blood stream, relaxing and widening the blood vessels. Potentially serious side effects of this medication include uncontrollable movement of the legs, arms, or hands, an irregular heartbeat, or heart failure .(2) Symptoms of heart failure include a sudden weight gain of at least five pounds (2.3 kilograms), chest pain, or swelling in the legs and ankles.